BR0105162A - Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do dna e método para a obtenção da cepa - Google Patents
Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do dna e método para a obtenção da cepaInfo
- Publication number
- BR0105162A BR0105162A BR0105162-8A BR0105162A BR0105162A BR 0105162 A BR0105162 A BR 0105162A BR 0105162 A BR0105162 A BR 0105162A BR 0105162 A BR0105162 A BR 0105162A
- Authority
- BR
- Brazil
- Prior art keywords
- strain
- obtaining
- insulin precursor
- dna constructs
- yeast strain
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 4
- 239000002243 precursor Substances 0.000 title abstract 4
- 102000004877 Insulin Human genes 0.000 title abstract 3
- 108090001061 Insulin Proteins 0.000 title abstract 3
- 229940125396 insulin Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 3
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 3
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004475 Arginine Chemical group 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
- 238000004690 coupled electron pair approximation Methods 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000235058 Komagataella pastoris Species 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"CEPA DE LEVEDURAS METILOTRóFICAS RECOMBINANTES PRODUTORAS DE UM PRECURSOR DE INSULINA, CONSTRUçõES DO DNA E MéTODO PARA A OBTENçãO DA CEPA". Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do DNA e método para obter a cepa. A referida cepa compreende no seu genoma pelo menos uma cópia de uma primeira construção do DNA e de uma segunda construção do DNA, onde as referidas construções do DNA são capazes de dirigir a expressão e liberação ao meio de um precursor de insulina humana de fórmula: B(1-30)-Y1Y2-A(1-21), onde Y1 é lisina ou arginina; Y2 é lisina ou arginina; B(1-30) é o peptídeo B da insulina humana; e A(1-21) é o peptídeo A da insulina humana e onde a cepa de leveduras corresponde a uma cepa de levedura da Pichia pastoris.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP000104797A AR025646A1 (es) | 2000-09-13 | 2000-09-13 | Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0105162A true BR0105162A (pt) | 2002-05-21 |
Family
ID=3460837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0105162-8A BR0105162A (pt) | 2000-09-13 | 2001-09-12 | Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do dna e método para a obtenção da cepa |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7091032B2 (pt) |
| EP (1) | EP1211314A3 (pt) |
| AR (1) | AR025646A1 (pt) |
| BR (1) | BR0105162A (pt) |
| CA (1) | CA2357072C (pt) |
| MX (1) | MXPA01008690A (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1575967B1 (en) * | 2002-12-05 | 2009-02-18 | Wockhardt Limited | Process for the extraction and isolation of insulin from recombinant sources |
| CN100460508C (zh) * | 2004-11-03 | 2009-02-11 | 马延高 | 人胰岛素基因在甲醇酵母中的分泌表达方法 |
| DE102006031955A1 (de) * | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
| WO2008139496A1 (en) * | 2007-05-16 | 2008-11-20 | Bigtec Private Limited | Recombinant human insulin and a method thereof |
| DK2217265T3 (en) | 2007-11-20 | 2017-07-03 | Ambrx Inc | Modified insulin polypeptides and their use |
| RU2495131C2 (ru) * | 2008-02-19 | 2013-10-10 | Байокон Лимитид | Способ получения рекомбинантного инсулина гларгина |
| JP5860413B2 (ja) * | 2010-02-10 | 2016-02-16 | バイオコン リミテッド | タンパク質のグリコシル化を低下させる方法、その産生方法およびタンパク質 |
| CN105087724B (zh) * | 2014-05-04 | 2019-12-03 | 重庆派金生物科技有限公司 | 酵母重组表达门冬胰岛素的制备方法 |
| AU2019218315A1 (en) * | 2018-02-09 | 2020-07-09 | Jiangsu Hengrui Medicine Co., Ltd. | Codon optimized precursor gene and signal peptide gene of human insulin analogue |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431740A (en) | 1979-09-12 | 1984-02-14 | The Regents Of The University Of California | DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes |
| US4343898A (en) | 1980-02-11 | 1982-08-10 | Novo Industri A/S | Process for preparing esters of human insulin |
| NZ199391A (en) | 1981-01-02 | 1985-12-13 | Genentech Inc | Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin |
| DK58285D0 (da) | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
| DK129385A (da) | 1985-03-22 | 1986-09-23 | Novo Industri As | Peptider og fremstilling deraf |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| WO1992004363A1 (en) * | 1990-09-04 | 1992-03-19 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| US5460954A (en) | 1992-04-01 | 1995-10-24 | Cheil Foods & Chemicals, Inc. | Production of human proinsulin using a novel vector system |
| DE4405179A1 (de) | 1994-02-18 | 1995-08-24 | Hoechst Ag | Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken |
| US5955349A (en) * | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
| CN1125081C (zh) * | 1999-09-08 | 2003-10-22 | 中国科学院上海生物化学研究所 | 重组天然和新型人胰岛素及其制备方法 |
-
2000
- 2000-09-13 AR ARP000104797A patent/AR025646A1/es active IP Right Grant
-
2001
- 2001-08-27 MX MXPA01008690A patent/MXPA01008690A/es active IP Right Grant
- 2001-09-12 CA CA2357072A patent/CA2357072C/en not_active Expired - Fee Related
- 2001-09-12 US US09/955,259 patent/US7091032B2/en not_active Expired - Fee Related
- 2001-09-12 BR BR0105162-8A patent/BR0105162A/pt not_active IP Right Cessation
- 2001-09-13 EP EP01121987A patent/EP1211314A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1211314A3 (en) | 2002-07-10 |
| US7091032B2 (en) | 2006-08-15 |
| US20030104607A1 (en) | 2003-06-05 |
| CA2357072A1 (en) | 2002-03-13 |
| AR025646A1 (es) | 2002-12-04 |
| CA2357072C (en) | 2012-07-10 |
| MXPA01008690A (es) | 2004-08-12 |
| EP1211314A2 (en) | 2002-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0207325A (pt) | Métodos terapêuticos para doenças associadas com expressão diminuìda de gene de aop-1 ou aop-1 | |
| WO2003082183A3 (en) | Protein-based streptococcus pneumoniae vaccines | |
| BR0317994A (pt) | Cepas de levedura recombinante que produzem a fermentação de xilose | |
| BR0105162A (pt) | Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do dna e método para a obtenção da cepa | |
| DE69936784D1 (de) | Behandlung von gebärmutterhalskrebs | |
| UA97516C2 (ru) | Полностью человеческое моноклональное антитело против vap-1 | |
| BR0311877A (pt) | Preparações ácidas de insulina com estabilidade aperfeiçoada | |
| AU2003244855A1 (en) | Method to enhance an immune response of nucleic acid vaccination | |
| BR0213565A (pt) | Anticorpo de anti-tnf alfa modificado | |
| EE200200709A (et) | Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine | |
| ATE430558T1 (de) | Herstellung von mikrokügelchen | |
| WO2003028757A1 (fr) | Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes | |
| DE69841015D1 (de) | Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2 | |
| BR0308507A (pt) | Engenharia metabólica para a utilização de xilose aperfeiçoada de saccharomyces cerevisiae | |
| WO2001087350A3 (en) | Treatment of human papillomavirus (hpv)-infected cells | |
| WO2002081709A3 (en) | Modified hpv e6 and e7 genes and proteins useful for vaccination | |
| ATE317016T1 (de) | Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten | |
| MX344751B (es) | Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| WO2006014234A3 (en) | Novel recombinant poxvirus composition and uses thereof | |
| AU2002317474A1 (en) | Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof | |
| WO2003016474A3 (en) | Methods and compositions for use in selectively producing a protein in telomerase expressing cells | |
| WO2003075849A3 (en) | Composition and method for enhancing immune response | |
| WO2006097945A3 (en) | A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure | |
| EP1541135A4 (en) | HOLLOWING NANOTEILS WITH MODIFIED CYSTEIN REST AND MEDICAMENT WITH APPROPRIATE USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2323 DE 14-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |